40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?

8Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Based on early evidence of in vitro neurotoxicity following exposure to serum derived from patients with amyotrophic lateral sclerosis (ALS), several studies have attempted to explore whether cerebrospinal fluid (CSF) obtained from people with ALS could possess similar properties. Although initial findings proved inconclusive, it is now increasingly recognized that ALS-CSF may exert toxicity both in vitro and in vivo. Nevertheless, the mechanism underlying CSF-induced neurodegeneration remains unclear. This review aims to summarize the 40-year long history of CSF toxicity studies in ALS, while discussing the various mechanisms that have been proposed, including glutamate excitotoxicity, proteotoxicity and oxidative stress. Furthermore, we consider the potential implications of a toxic CSF circulatory system in the pathophysiology of ALS, and also assess its significance in the context of current ALS research.

Cite

CITATION STYLE

APA

Ng Kee Kwong, K. C., Harbham, P. K., Selvaraj, B. T., Gregory, J. M., Pal, S., Hardingham, G. E., … Mehta, A. R. (2021, March 18). 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? Frontiers in Molecular Neuroscience. Frontiers Media S.A. https://doi.org/10.3389/fnmol.2021.647895

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free